Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CGTX

CGTX News

Newswire

10:04

Cognition Therapeutics' Cash Burn and Future Prospects

06:17

HC Wainwright Raises Cognition Therapeutics Buy Rating to $3

11:48

Cognition shares jump 10.87% intraday after completing expanded access program enrollment for zervimesine in DLB, funded by family donation.

07:35

Cognition Therapeutics' Expanded Access Program for Zervimesine Reaches Full Enrollment.

07:32

Cognition Therapeutics Expands Zervimesine Access Program, Reaches Full Enrollment in Dementia with Lewy Bodies Trial

View More

About CGTX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More